These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16377451)

  • 1. Outpatient substance abuse treatment and HIV prevention: an update.
    Pollack HA; D'Aunno T; Lamar B
    J Subst Abuse Treat; 2006 Jan; 30(1):39-47. PubMed ID: 16377451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervisor ideology and organizational response: HIV/AIDS prevention in outpatient substance abuse treatment units.
    Clapp JD; Burke AC
    Adm Soc Work; 1997; 21(1):49-64. PubMed ID: 10166759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units.
    D'Aunno T; Vaughn TE; McElroy P
    J Health Soc Behav; 1999 Jun; 40(2):175-92. PubMed ID: 10467763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005.
    Pollack HA; D'Aunno T
    J Subst Abuse Treat; 2010 Jun; 38(4):307-16. PubMed ID: 20171038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAPT: Association for Drug Abuse and Prevention and Treatment.
    Cintron M
    Newsline People AIDS Coalit N Y; 1998 Jun; ():13-7. PubMed ID: 11367467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who cares for involuntary clients?
    Soliman S; Pollack HA; Alexander JA
    Subst Abus; 2009; 30(1):1-13. PubMed ID: 19197777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus prevention and the potential of drug abuse treatment.
    Metzger DS; Navaline H
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S451-6. PubMed ID: 14648463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of human immunodeficiency virus testing and posttest counseling among outpatients with serious mental illness.
    Desai MM; Rosenheck RA; Desai RA
    J Nerv Ment Dis; 2007 Sep; 195(9):776-80. PubMed ID: 17984780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State policies matter: the case of outpatient drug treatment program practices.
    Chriqui JF; Terry-McElrath Y; McBride DC; Eidson SS
    J Subst Abuse Treat; 2008 Jul; 35(1):13-21. PubMed ID: 17936550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005.
    Alexander JA; Nahra TA; Lemak CH; Pollack H; Campbell CI
    J Subst Abuse Treat; 2008 Apr; 34(3):282-92. PubMed ID: 17600653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive Health Project.
    Farrell J
    Newsline People AIDS Coalit N Y; 1998 Jun; ():18-20. PubMed ID: 11367468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Integration of the public health service in community management of substance dependent patients].
    Behrends K
    Offentl Gesundheitswes; 1991; 53(8-9):543-5. PubMed ID: 1837888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the risk of HIV infection associated with illicit drug use.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2006 Feb; 117(2):566-71. PubMed ID: 16452382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community action for preventing HIV in Cambodia: evaluation of a 3-year project.
    Sopheab H; Fylkesnes K; Lim Y; Godwin P
    Health Policy Plan; 2008 Jul; 23(4):277-87. PubMed ID: 18562460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief motivational intervention to reduce HIV risk and to increase HIV testing among offenders under community supervision.
    Alemagno SA; Stephens RC; Stephens P; Shaffer-King P; White P
    J Correct Health Care; 2009 Jul; 15(3):210-21. PubMed ID: 19477803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailoring of outpatient substance abuse treatment to women, 1995-2005.
    Campbell CI; Wells R; Alexander JA; Jiang L; Nahra TA; Lemak CH
    Med Care; 2007 Aug; 45(8):775-80. PubMed ID: 17667312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV testing among at-risk adolescents and young adults: a prospective analysis of a community sample.
    Tolou-Shams M; Payne N; Houck C; Pugatch D; Beausoleil N; Brown LK;
    J Adolesc Health; 2007 Dec; 41(6):586-93. PubMed ID: 18023788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.